Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
作者信息
Ahmann D L, Edmonson J H, Frytak S, Kvols L K, Bisel H F, Rubin J
出版信息
Cancer Treat Rep. 1978 Jan;62(1):151-3.
PMID:626995
Abstract
摘要
Zotero 插件